You are here

Choe, Jennifer Hsing

Positions:

Medical Instructor in the Department of Medicine

Medicine, Medical Oncology
School of Medicine

Member of the Duke Cancer Institute

Duke Cancer Institute
School of Medicine

Education:

MD./PhD. 2011

MD./PhD. — University of Texas MD Anderson Cancer Center

Internal Medicine Residency

Baylor College of Medicine

Hematology-Oncology Fellowship, Medicine

Duke University School of Medicine

Grants:

BLU-285-1303

Administered By
Duke Cancer Institute
AwardedBy
Blueprint Medicines Corporation
Role
Principal Investigator
Start Date
July 24, 2018
End Date
July 31, 2023

Genmab GCT1021-01

Administered By
Duke Cancer Institute
AwardedBy
Genmab A/S
Role
Principal Investigator
Start Date
June 29, 2018
End Date
July 01, 2023

AstraZeneca REFMAL 435

Administered By
Duke Cancer Institute
AwardedBy
AstraZeneca Pharmaceuticals, LP
Role
Principal Investigator
Start Date
December 20, 2017
End Date
September 30, 2022

RIFTOS MKI (Bayer Observational Study) Number 17852 NX1401

Administered By
Duke Cancer Institute
AwardedBy
Bayer Healthcare Pharmaceuticals Inc
Role
Principal Investigator
Start Date
November 01, 2015
End Date
October 31, 2020

Anti-Tumor Effects of locally and Systemically Administered EZN-2279 monotherapy in a murine model of Colorectal Carcinoma

Administered By
Medicine, Medical Oncology
AwardedBy
Leadiant Biosciences, Inc.
Role
Investigator
Start Date
May 01, 2017
End Date
September 30, 2018
Show More